Skip to main content
Filters

    Results for Activators & Inhibitors ( 79992 )

      • Ref: T61984
        Sizes: 5 mg, 100 mg, 50 mg

        MtMetAP1-IN-1 is an inhibitor of methionine aminopeptidase 1 ( MetAP1 ). MtMetAP1-IN-1 shows antimycobacterial activity.

        Product detail
      • Ref: T61985
        Sizes: 25 mg, 50 mg

        EHT 5372 is a potent and selective inhibitor of DYRK’s family kinases. EHT 5372 shows IC 50 s of 0.22, 0.28, 10.8, 93.2, 22.8, 88.8, 59.0, 7.44, 221 nM for DYRK1A, DYRK1B, DYRK2, DYRK3, CLK1, CLK2, CLK4, GSK-3α, GSK-3β.

        Product detail
      • Ref: T61986
        Sizes: 5 mg, 25 mg, 100 mg, 50 mg

        PRMT5-IN-21 (compound 1) is a potent inhibitor of cyclonucleoside PRMT5.

        Product detail
      • Ref: T61987
        Sizes: 100 mg, 50 mg

        PHA 568487 a selective agonist of alpha-7 nicotinic acetylcholine receptor ( α-7 nAchR ). PHA-568487 shows rapid brain penetration. PHA 568487 reduces oxidative stress and neuroinflammation.

        Product detail
      • Ref: T61988
        Sizes: 5 mg, 100 mg, 50 mg

        Ruxolitinib sulfate (INCB018424 sulfate) is a potent, selective JAK1/2 inhibitor with IC 50 s of 3.3 nM/2.8 nM. Ruxolitinib sulfate shows > 130-fold selectivity for JAK1/2 versus JAK3.

        Product detail
      • Ref: T61989
        Sizes: 5 mg, 25 mg, 100 mg, 50 mg, 10 mg

        CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.

        Product detail
      • Ref: T61990
        Sizes: 5 mg, 100 mg, 50 mg

        Topoisomerase I/II inhibitor 3 (compound 7) is a potent dual inhibitor of topoisomerase I (Topo I) and II (Topo II) . By inhibiting PI3K /Akt/mTOR signaling pathway, Topoisomerase I/II inhibitor 3 can inhibit cell proliferation, invasion and migration, and induce apoptosis . Topoisomerase I/II inhibitor 3 has research value in liver cancer.

        Product detail
      • Ref: T61991
        Sizes: 5 mg, 25 mg, 100 mg, 50 mg

        HTT-D3 is a potent and orally active huntingtin (HTT) splicing modulator. HTT-D3 can lead to HTT mRNA degradation and reduction of HTT levels. HTT-D3 reduces p-glycoprotein (P-gp) efflux, and has research value in Huntington's disease.

        Product detail
      • Ref: T61993
        Sizes: 5 mg, 100 mg, 50 mg

        SW-034538 is a TAO2 inhibitor (IC 50= 300 nM).

        Product detail